(Q56967207)
Statements
IL-2 phase II trial in metastatic melanoma: analysis of clinical and immunological parameters (English)
0 references
Dorval T
Mathiot C
Chosidow O
Revuz J
Avril MF
Guillaume JC
Tursz T
Brandely M
1992
0 references
3
0 references
1-2
0 references
63-79
0 references